|
| No. | Accession | Description | Coverage | Proteins | Unique peptides | Fold change cancer/normal |
|
| 1 | B2R950 | cDNA, FLJ94213, highly similar to Homo sapiens pregnancy zone protein (PZP), mRNA | 9.99 | 6 | 9 | 0.5155859 |
| 2 | P01023 | Alpha-2-macroglobulin | 41.93 | 7 | 42 | 1.9621536 |
| 3 | A8K5T0 | cDNA FLJ75416, highly similar to Homo sapiens complement factor H (CFH), mRNA | 51.34 | 5 | 1 | 1.2850993 |
| 4 | P02656 | Apolipoprotein C-III | 34.34 | 2 | 3 | 0.661148 |
| 5 | P01009 | Alpha-1-antitrypsin | 26.56 | 18 | 10 | 1.7751413 |
| 6 | B0AZL7 | cDNA, FLJ79457, highly similar to insulin-like growth factor binding protein complex acid labile chain | 35.87 | 3 | 18 | 0.7544295 |
| 7 | A8K2T4 | cDNA FLJ78207, highly similar to human complement protein component C7 mRNA | 50.77 | 6 | 2 | 1.6921352 |
| 8 | P06727 | Apolipoprotein A-IV | 72.22 | 38 | 25 | 1.3346624 |
| 9 | Q6LAN8 | Collagen type I alpha 1 (fragment) | 1.68 | 3 | 2 | 0.3289969 |
| 10 | P27169 | Serum paraoxonase/arylesterase 1 | 18.87 | 10 | 6 | 0.7979568 |
| 11 | Q86TT2 | Full-length cDNA clone CS0DI019YF20 of the placenta of Homo sapiens (human) (fragment) | 24.58 | 20 | 5 | 1.3549255 |
| 12 | A6XND1 | Insulin-like growth factor binding protein 3 isoform b | 13.31 | 18 | 3 | 0.8091975 |
| 13 | K7ER74 | Apolipoprotein C-IV | 33.15 | 6 | 5 | 0.7221412 |
| 14 | H3BRJ9 | Cholesteryl ester transfer protein | 3.5 | 5 | 1 | 0.7701269 |
| 15 | P0CG05 | Ig lambda-2 chain C regions | 50.94 | 47 | 3 | 1.2929291 |
| 16 | K7ERI9 | Truncated apolipoprotein C-I (fragment) | 23.38 | 6 | 2 | 0.6776806 |
| 17 | B2R773 | cDNA, FLJ93312, highly similar to Homo sapiens adipose most abundant gene transcript 1 (APM1), mRNA | 6.15 | 2 | 1 | 1.2836387 |
| 18 | Q8N567 | Zinc finger CCHC domain-containing protein 9 | 12.92 | 1 | 1 | 2.205296 |
| 19 | P51884 | Lumican | 40.24 | 2 | 12 | 1.2781468 |
| 20 | D3JV41 | Thrombocidin-2 antimicrobial variant (fragment) | 38.1 | 4 | 5 | 0.7778097 |
| 21 | Q59GZ2 | PLEK protein variant (fragment) | 1.95 | 2 | 1 | 0.7092328 |
| 22 | Q5T0R7 | Adenylyl cyclase-associated protein (fragment) | 7.47 | 14 | 1 | 0.8056854 |
| 23 | P02741 | C-reactive protein | 23.66 | 3 | 6 | 0.7119999 |
| 24 | Q68CK4 | Leucine-rich alpha-2-glycoprotein | 43.8 | 2 | 1 | 0.7878539 |
| 25 | P02747 | Complement C1q subcomponent subunit C | 15.92 | 1 | 3 | 1.2504316 |
| 26 | B4DTB1 | cDNA FLJ52936, weakly similar to tropomyosin alpha-4 chain | 20.78 | 35 | 2 | 0.7363925 |
| 27 | Q7LC44 | Activity-regulated cytoskeleton-associated protein | 2.78 | 1 | 1 | 1.4207039 |
| 28 | D6R904 | Tropomyosin alpha-3 chain | 23.16 | 37 | 1 | 0.8191275 |
| 29 | I2D5I8 | Apolipoprotein M (fragment) | 15.12 | 4 | 2 | 0.7276038 |
| 30 | Q6NSB4 | HP protein | 9.61 | 8 | 3 | 0.8037301 |
| 31 | J3KRP0 | Beta-Ala-His dipeptidase | 7.76 | 4 | 3 | 0.8289956 |
| 32 | B7Z590 | Cadherin-13 | 3.41 | 3 | 1 | 1.295513 |
| 33 | A6NIW5 | Peroxiredoxin 2, isoform CRA_a | 19.85 | 3 | 2 | 1.2729786 |
| 34 | C9JUM4 | EGF-containing fibulin-like extracellular matrix protein 1 (fragment) | 20.97 | 8 | 1 | 1.3872657 |
| 35 | P08603 | Complement factor H | 52.15 | 7 | 2 | 0.7693435 |
| 36 | K7EJ44 | Profilin 1, isoform CRA_b | 26.92 | 2 | 2 | 0.7312391 |
| 37 | B2RA39 | cDNA, FLJ94686, highly similar to Homo sapiens complement factor H-related 5 (CFHL5), mRNA | 3.87 | 4 | 1 | 0.803087 |
| 38 | P01011 | Alpha-1-antichymotrypsin | 40.19 | 4 | 14 | 0.802004 |
| 39 | B2RAL6 | cDNA, FLJ94991, highly similar to Homo sapiens integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide) (ITGAL), mRNA | 0.6 | 2 | 1 | 0.8038053 |
| 40 | J3QSE5 | Phosphatidylcholine-sterol acyltransferase (fragment) | 9.8 | 4 | 2 | 0.7909272 |
| 41 | B4E1C4 | cDNA FLJ51179, highly similar to vitamin K-dependent protein C (EC 3.4.21.69) | 16.63 | 16 | 4 | 0.8316701 |
|
